Molecular cancer diagnostics company
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Stanley Druckenmiller / Duquesne | 81 | New buy | 1,894,450 | $33,873 | 1.0% |
| Ancora | 38 | Added +1226% | 1,923 | $34,383 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.